Schedule 13D ownership disclosure

ACADIA Pharmaceuticals Inc

Security class unavailable · CUSIP: 004225108

Event date: 2016-03-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
24,566,113
Percent of class
21.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-16-092320
Form type
SC 13D/A
Filer
ACADIA PHARMACEUTICALS INC
CIK
CIK 1070494
Filed
Apr 01, 2016
Reporting period
Mar 31, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub